{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:06:16Z","timestamp":1649095576806},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,9,16]],"date-time":"2004-09-16T00:00:00Z","timestamp":1095292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s00210-004-0972-z","type":"journal-article","created":{"date-parts":[[2004,9,15]],"date-time":"2004-09-15T14:18:41Z","timestamp":1095257921000},"page":"305-313","source":"Crossref","is-referenced-by-count":0,"title":["3H-noradrenaline release from mouse iris?ciliary body: role of presynaptic muscarinic heteroreceptors"],"prefix":"10.1007","volume":"370","author":[{"given":"Michel","family":"Bernhard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Haslebacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Lambrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Ulrike","family":"Trendelenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,9,16]]},"reference":[{"key":"CR1","volume-title":"TiPS receptor and ion channel nomenclature supplement 2001","author":"SPH Alexander","year":"2001","unstructured":"Alexander SPH, Mathie A, Peters JA (2001) TiPS receptor and ion channel nomenclature supplement 2001. Elsevier, Cambridge"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/mol.56.1.154","volume":"56","author":"JD Altmann","year":"1999","unstructured":"Altmann JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, Kobilka BK, Hein L (1999) Abnormal regulation of the sympathetic nervous system in ?2A-adrenergic receptor knockout mice. Mol Pharmacol 56:154?161","journal-title":"Mol Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/pr.54.1.43","volume":"54","author":"S Boehm","year":"2002","unstructured":"Boehm S, Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43?99","journal-title":"Pharmacol Rev"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1476-5381.1988.tb11601.x","volume":"94","author":"IT Bognar","year":"1988","unstructured":"Bognar IT, Pallas S, Fuder H, Muscholl E (1988) Muscarinic inhibition of [3H]-noradrenaline release on rabbit iris in vitro: effects of stimulation conditions on intrinsic activity of methacholine and pilocarpine. Br J Pharmacol 94:890?900","journal-title":"Br J Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(89)90195-7","volume":"163","author":"IT Bognar","year":"1989","unstructured":"Bognar IT, Baumann B, Dammann F, Kn\u00f6ll B, Meincke M, Pallas S, Fuder H (1989) M2 muscarinic receptors on the iris sphincter muscle differ from those on iris noradrenergic nerves. Eur J Pharmacol 163:263?274","journal-title":"Eur J Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00164573","volume":"345","author":"IT Bognar","year":"1992","unstructured":"Bognar IT, Altes U, Beinhauer C, Kessler I, Fuder H (1992) A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter. Naunyn-Schmiedebergs Arch Pharmacol 345:611?618","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/02713688609015134","volume":"5","author":"JA Burke","year":"1986","unstructured":"Burke JA, Potter DE (1986) Ocular effects of a relatively selective alpha 2 agonist (UK-14,304-18) in cats, rabbits and monkeys. Curr Eye Res 5:665?676","journal-title":"Curr Eye Res"},{"key":"CR8","first-page":"279","volume":"50","author":"MP Caulfield","year":"1998","unstructured":"Caulfield MP, Birdsall NJM (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279?290","journal-title":"Pharmacol Rev"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1006\/exer.1999.0734","volume":"69","author":"E Chu","year":"1999","unstructured":"Chu E, Chu TC, Potter DE (1999) Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp Eye Res 69:611?616","journal-title":"Exp Eye Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1476-5381.1991.tb12266.x","volume":"102","author":"M Costa","year":"1991","unstructured":"Costa M, Majewski H (1991) Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria. Br J Pharmacol 102:855?860","journal-title":"Br J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1076\/ceyr.16.4.359.10690","volume":"16","author":"CE Crosson","year":"1997","unstructured":"Crosson CE, Gray T (1997) Response to prejunctional adenosine receptors is dependent on stimulus frequency. Curr Eye Res 16:359?364","journal-title":"Curr Eye Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00173576","volume":"339","author":"F Dammann","year":"1989","unstructured":"Dammann F, Fuder H, Giachetti A, Giraldo E, Kilbinger H, Micheletti R (1989) AF-DX 116 differentiates between prejunctional muscarine receptors located on noradrenergic and cholinergic nerves. Naunyn-Schmiedebergs Arch Pharmacol 339:268?271","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504223","volume":"315","author":"F Drago","year":"1980","unstructured":"Drago F, Gorgone G, Spina F, Panissidi G, Dal Bello A, Moro F, Scapagnini U (1980) Opiate receptors in the rabbit iris. Naunyn-Schmiedebergs Arch Pharmacol 315:1?4","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.2042-7158.1970.tb08455.x","volume":"22","author":"LO Farnebo","year":"1970","unstructured":"Farnebo LO, Hamberger B (1970) Effects of desipramine, phentolamine and phenoxybenzamine on the release of noradrenaline from isolated tissues. J Pharm Pharamcol 22:855?857","journal-title":"J Pharm Pharamcol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1476-5381.1971.tb07160.x","volume":"43","author":"LO Farnebo","year":"1971","unstructured":"Farnebo LO, Hamberger B (1971) Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris. Br J Pharmacol 43:97?106","journal-title":"Br J Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/jop.1994.10.109","volume":"10","author":"H Fuder","year":"1994","unstructured":"Fuder H (1994) Functional consequences of prejunctional receptor activation or blockade in the iris. J Ocul Pharmacol 10:109?123","journal-title":"J Ocul Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BFb0049778","volume":"126","author":"H Fuder","year":"1995","unstructured":"Fuder H, Muscholl E (1995) Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol 126:265?412","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"CR18","first-page":"352","volume":"348","author":"H Fuder","year":"1993","unstructured":"Fuder H, Muth U (1993) ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2Y-like purinoreceptors. Naunyn-Schmiedebergs Arch Pharmacol 348:352?357","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR19","first-page":"611","volume":"345","author":"H Fuder","year":"1989","unstructured":"Fuder H, Sch\u00f6pf J, Unckell J, Wesner MT, Melchiorre C, Tacke R, Mutschler E, Lambrecht G (1989) Different muscarine receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle. Naunyn-Schmiedebergs Arch Pharmacol 345:611?618","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00176619","volume":"345","author":"H Fuder","year":"1992","unstructured":"Fuder H, Brink A, Meincke M, Tauber U (1992) Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]-noradrenaline release on rat iris. Naunyn-Schmiedebergs Arch Pharmacol 345:417?423","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR21","first-page":"283","volume-title":"Catecholamines. Handbook of experimental pharmacology","author":"RF Furchgott","year":"1972","unstructured":"Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283?335"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.2000.0752087.x","volume":"75","author":"I G\u00f6bel","year":"2000","unstructured":"G\u00f6bel I, Trendelenburg AU, Cox SL, Meyer A, Starke K (2000) Electrically evoked release of [3H]noradrenaline from mouse cultured sympathetic neurons: release-modulating heteroreceptors. J Neurochem 75:2087?2094","journal-title":"J Neurochem"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/10807680260218506","volume":"18","author":"LC Harris","year":"2002","unstructured":"Harris LC, Awe SO, Opere CA, LeDay AM, Ohia SE (2002) Pharmacology of serotonin receptors modulating electrically-induced [3H]-noradrenaline release from isolated mammalian iris?ciliary bodies. J Ocul Pharmacol Ther 18:339?348","journal-title":"J Ocul Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BFb0117493","volume":"142","author":"L Hein","year":"2001","unstructured":"Hein L (2001) Transgenic models of ?2-adrenergic receptor subtype function. Rev Physiol Biochem Pharmacol 142:161?185","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/46040","volume":"402","author":"L Hein","year":"1999","unstructured":"Hein L, Altman JD, Kobilka BK (1999) Two functionally distinct ?2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402:181?184","journal-title":"Nature"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/jop.1994.10.617","volume":"10","author":"JE Jumblatt","year":"1994","unstructured":"Jumblatt JE (1994) Prejunctional alpha 2-adrenoceptors and adenylyl cyclase regulation in the rabbit iris?ciliary body. J Ocul Pharmacol 10:617?621","journal-title":"J Ocul Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/02713689008995203","volume":"9","author":"JE Jumblatt","year":"1990","unstructured":"Jumblatt JE, Hackmiller RC (1990) Potentiation of norepinephrine secretion by angiotensin II in the isolated rabbit iris?ciliary body. Curr Eye Res 9:169?176","journal-title":"Curr Eye Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/exer.1994.1005","volume":"58","author":"JE Jumblatt","year":"1994","unstructured":"Jumblatt JE, Hackmiller RC (1994) M2-type muscarinic receptors mediate prejunctional inhibition of norepinephrine release in the human iris?ciliary body. Exp Eye Res 58:175?180","journal-title":"Exp Eye Res"},{"key":"CR27","first-page":"615","volume":"29","author":"JE Jumblatt","year":"1988","unstructured":"Jumblatt JE, North GT (1988) Cholinergic inhibition of adrenergic neurosecretion in the rabbit iris?ciliary body. Invest Ophthalmol Vis Sci 29:615?620","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/02713688709034843","volume":"6","author":"JE Jumblatt","year":"1987","unstructured":"Jumblatt JE, Liu JG, North GT (1987) Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris?ciliary body. Curr Eye Res 6:767?777","journal-title":"Curr Eye Res"},{"key":"CR31","first-page":"2790","volume":"34","author":"JE Jumblatt","year":"1993","unstructured":"Jumblatt JE, Ohia SE, Hackmiller RC (1993) Prejunctional modulation of norepinephrine release in the human iris?ciliary body. Invest Ophthalmol Vis Sci 34:2790?2793","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00164790","volume":"348","author":"MC Koss","year":"1993","unstructured":"Koss MC, Hey JA (1993) Prejunctional inhibition of sympathetically evoked pupillary dilatation in cats by activation of histamine H3 receptors. Naunyn-Schmiedebergs Arch Pharmacol 348:141?145","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR33","first-page":"e-abstract 1975","volume":"43","author":"KH Kulkarni","year":"2002","unstructured":"Kulkarni KH, LeDay AM, Opere CA, Ohia SE (2002) Pharmacology of prejunctional histamine receptors on sympathetic nerves in isolated mammalian irides. Invest Ophthalmol Vis Sci 43:e-abstract 1975","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-6147(96)01034-6","volume":"18","author":"SZ Langer","year":"1997","unstructured":"Langer SZ (1997) 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18:95?99","journal-title":"Trends Pharmacol Sci"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1476-5381.1992.tb14494.x","volume":"107","author":"N Limberger","year":"1992","unstructured":"Limberger N, Trendelenburg AU, Starke K (1992) Pharmacological characterization of presynaptic ?2-autoreceptors in rat submaxillary gland and heart atrium. Br J Pharmacol 107:246?255","journal-title":"Br J Pharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0014-4835(75)90222-5","volume":"20","author":"AH Neufeld","year":"1975","unstructured":"Neufeld AH, Page ED (1975) Regulation of adrenergic neuromuscular transmission in the rabbit iris. Exp Eye Res 20:549?561","journal-title":"Exp Eye Res"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/eye.1999.78","volume":"13","author":"GW Nietgen","year":"1999","unstructured":"Nietgen GW, Schmidt J, Hesse L, H\u00f6nemann CW, Durieux ME (1999) Muscarinic receptor functioning and distribution in the eye: molecular basis and implications for clinical diagnosis and therapy. Eye 13:285?300","journal-title":"Eye"},{"key":"CR38","first-page":"822","volume":"267","author":"M Ogidigben","year":"1993","unstructured":"Ogidigben M, Chu TC, Potter DE (1993) Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther 267:822?827","journal-title":"J Pharmacol Exp Ther"},{"key":"CR39","first-page":"11","volume":"255","author":"SE Ohia","year":"1990","unstructured":"Ohia SE, Jumblatt JE (1990a) Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris?ciliary body. J Pharmacol Exp Ther 255:11?16","journal-title":"J Pharmacol Exp Ther"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00968668","volume":"15","author":"SE Ohia","year":"1990","unstructured":"Ohia SE, Jumblatt JE (1990b) Inhibitory effects of neuropeptide Y on sympathetic neurotransmission in the rabbit iris?ciliary body. Neurochem Res 15:251?256","journal-title":"Neurochem Res"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/02713689109020333","volume":"10","author":"SE Ohia","year":"1991","unstructured":"Ohia SE, Jumblatt JE (1991) Prejunctional prostaglandin receptors in the human iris?ciliary body. Curr Eye Res 10:967?975","journal-title":"Curr Eye Res"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1993.1143","volume":"57","author":"SE Ohia","year":"1993","unstructured":"Ohia SE, Jumblatt JE (1993) Prejunctional receptors and second messengers for angiotensin II in the rabbit iris?ciliary body. Exp Eye Res 57:419?425","journal-title":"Exp Eye Res"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1020764220449","volume":"23","author":"CA Opere","year":"1998","unstructured":"Opere CA, Ohia SE (1998) Prejunctional alpha2-adrenoceptors and peroxide-induced potentiation of norepinephrine release from the bovine iris. Neurochem Res 23:1093?1098","journal-title":"Neurochem Res"},{"key":"CR44","first-page":"941","volume":"298","author":"KR Russel","year":"2001","unstructured":"Russel KR, Potter DE (2001) Biphasic alterations of cAMP and inhibition of norepinephrine release in iris?ciliary body by bremazocine. J Pharmacol Exp Ther 298:941?946","journal-title":"J Pharmacol Exp Ther"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0361-9230(98)00068-9","volume":"47","author":"E Schlicker","year":"1998","unstructured":"Schlicker E, G\u00f6thert M (1998) Interactions between the presynaptic ?2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47:129?132","journal-title":"Brain Res Bull"},{"key":"CR46","first-page":"e-abstract 3273","volume":"43","author":"M Shara","year":"2002","unstructured":"Shara M, Kulkarni KH, Ohia SE (2002) Effect of cannabinoids on sympathetic neurotransmission in isolated bovine irides. Invest Ophthalmol Vis Sci 43:e-abstract 3273","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR47","first-page":"204","volume":"255","author":"GT Somogyi","year":"1990","unstructured":"Somogyi GT, de Groat WC (1990) Modulation of the release of [3H]norepinephrine from the base and body of the rat urinary bladder by endogenous adrenergic and cholinergic mechanisms. J Pharmacol Exp Ther 255:204?210","journal-title":"J Pharmacol Exp Ther"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BFb0027645","volume":"107","author":"K Starke","year":"1987","unstructured":"Starke K (1987) Presynaptic ?-autoreceptors. Rev Physiol Biochem Pharmacol 107:73?146","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/PL00005111","volume":"356","author":"AU Trendelenburg","year":"1997","unstructured":"Trendelenburg AU, Sutej I, Wahl CA, Molderings GJ, Rump LC, Starke K (1997) A re-investigation of questionable subclassifications of presynaptic ?2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedebergs Arch Pharmacol 356:721?737","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s002109900093","volume":"360","author":"AU Trendelenburg","year":"1999","unstructured":"Trendelenburg AU, Hein L, Gaiser EG, Starke K (1999) Occurrence, pharmacology and function of presynaptic ?2-autoreceptors in ?2A\/D-adrenoceptor-deficient mice. Naunyn-Schmiedebergs Arch Pharmacol 360:540?551","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bjp.0703305","volume":"130","author":"AU Trendelenburg","year":"2000","unstructured":"Trendelenburg AU, Cox SL, Schelb V, Klebroff W, Khairallah L, Starke K (2000) Modulation of 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and ?-adrenoceptors in mouse tissues. Br J Pharmacol 130:321?330","journal-title":"Br J Pharmacol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002100100423","volume":"364","author":"AU Trendelenburg","year":"2001","unstructured":"Trendelenburg AU, Klebroff W, Hein L, Starke K (2001) A study of presynaptic ?2-autoreceptors in ?2A\/D-, ?2B-, ?2C-adrenoceptor-deficient mice. Naunyn-Schmiedebergs Arch Pharmacol 364:117?130","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00210-003-0829-x","volume":"368","author":"AU Trendelenburg","year":"2003","unstructured":"Trendelenburg AU, Philipp M, Meyer A, Klebroff W, Hein L, Starke K (2003a) All three ?2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons. Naunyn-Schmiedebergs Arch Pharmacol 368:504?512","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjp.0705053","volume":"138","author":"AU Trendelenburg","year":"2003","unstructured":"Trendelenburg AU, Gomeza J, Klebroff W, Zhou H, Wess J (2003b) Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice. Br J Pharmacol 138:469?480","journal-title":"Br J Pharmacol"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4615-8198-7_4","volume-title":"Advances in general and cellular pharmacology","author":"DR Waud","year":"1976","unstructured":"Waud DR (1976) Analysis of dose?response relationships. In: Narahshi T, Bianchi CP (eds) Advances in general and cellular pharmacology, vol 1. Plenum, New York, pp 145?178"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0165-6147(03)00195-0","volume":"24","author":"J Wess","year":"2003","unstructured":"Wess J (2003) Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci 24:414?420","journal-title":"Trends Pharmacol Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-004-0972-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-004-0972-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-004-0972-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:01:59Z","timestamp":1558641719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-004-0972-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,16]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s00210-004-0972-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,16]]}}}